Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Paul

Showing results (531-540 of 704) with videos related to

Pageof 71
Sort By:
Human Molecular Genetics|August 21, 2009
Investigating the genetic association between ERAP1 and ankylosing spondylitisDavid Harvey, Jennifer J Pointon, David M Evans, et al.
Abdominal Radiology (New York)|June 24, 2017
Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastographyShashi B Paul, Prasenjit Das, Mousumi Mahanta, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|February 18, 2011
Analysis of sexually dimorphic expression of genes at early gonadogenesis of pejerrey Odontesthes bonariensis using a heterologous microarrayJ I Fernandino, J T Popesku, B Paul-Prasanth, et al.
Protein Science : a Publication of the Protein Society|August 24, 2004
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coliJennifer White, Petra Lukacik, Dirk Esser, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Myasthenia gravis seronegative for acetylcholine receptor antibodiesAngela Vincent, Maria Isabel Leite, Maria Elena Farrugia, et al.
Journal of Neuroinflammation|January 10, 2009
Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in micePhilip F Stahel, Michael A Flierl, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milkEmmanuel LeBouder, Julia E Rey-Nores, Neil K Rushmere, et al.
Molecular Immunology|April 17, 2015
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndromeRubén Martínez-Barricarte, Meike Heurich, Andrés López-Perrote, et al.
Kidney International|November 13, 2002
Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytesLihua Bao, O Brad Spiller, Patricia L St John, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2006
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeElena Goicoechea de Jorge, Claire L Harris, Jorge Esparza-Gordillo, et al.
Pageof 71

Showing results (531-540 of 704) with videos related to

Sort By:
Pageof 71
Human Molecular Genetics|August 21, 2009
Investigating the genetic association between ERAP1 and ankylosing spondylitisDavid Harvey, Jennifer J Pointon, David M Evans, et al.
Abdominal Radiology (New York)|June 24, 2017
Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastographyShashi B Paul, Prasenjit Das, Mousumi Mahanta, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|February 18, 2011
Analysis of sexually dimorphic expression of genes at early gonadogenesis of pejerrey Odontesthes bonariensis using a heterologous microarrayJ I Fernandino, J T Popesku, B Paul-Prasanth, et al.
Protein Science : a Publication of the Protein Society|August 24, 2004
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coliJennifer White, Petra Lukacik, Dirk Esser, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Myasthenia gravis seronegative for acetylcholine receptor antibodiesAngela Vincent, Maria Isabel Leite, Maria Elena Farrugia, et al.
Journal of Neuroinflammation|January 10, 2009
Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in micePhilip F Stahel, Michael A Flierl, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milkEmmanuel LeBouder, Julia E Rey-Nores, Neil K Rushmere, et al.
Molecular Immunology|April 17, 2015
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndromeRubén Martínez-Barricarte, Meike Heurich, Andrés López-Perrote, et al.
Kidney International|November 13, 2002
Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytesLihua Bao, O Brad Spiller, Patricia L St John, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2006
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeElena Goicoechea de Jorge, Claire L Harris, Jorge Esparza-Gordillo, et al.
Pageof 71